Sab Biotherapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Sab Biotherapeutics (SABSW) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Sab Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Sab Biotherapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sab Biotherapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $538 | 23k | 0.02 |
| 2024-12-31 | $121 | 1.6k | 0.07 |
| 2024-06-30 | $3 | 56 | 0.05 |
| 2023-12-31 | $872 | 29k | 0.03 |
| 2023-06-30 | $10 | 100 | 0.10 |
| 2022-09-30 | $0 | 5.6k | 0.00 |
| 2021-12-31 | $5.0k | 2.9k | 1.73 |